ViraTherapeutics Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $243M

  • Investors
  • 1

ViraTherapeutics General Information

Description

Developer of a next-generation oncolytic viral therapy platform created for the treatment of cancer. The company develops highly potent anti-cancer therapeutics based on oncolytic viruses that efficiently destroy cancer cells while leaving normal tissues unharmed, enabling research scientists to develop oncolytic cancer vaccines based on a chimeric virus derived from the vesicular stomatitis virus.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • Bundesstraße 27
  • Rum, 6063
  • Austria
+43 0512
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Boehringer Ingelheim
Vertical(s)
Corporate Office
  • Bundesstraße 27
  • Rum, 6063
  • Austria
+43 0512

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ViraTherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 13-Sep-2018 $243M Completed Generating Revenue
7. Early Stage VC (Series B) 28-Oct-2016 Completed Generating Revenue
6. Early Stage VC (Series A) 24-Jun-2015 Completed Startup
5. Grant 01-Dec-2014 Completed Startup
4. Grant 01-Jul-2013 Completed Startup
3. Angel (individual) 01-Apr-2013 Completed Startup
2. Accelerator/Incubator Completed Startup
1. University Spin-Out 01-Apr-2013 Completed Startup
To view ViraTherapeutics’s complete valuation and funding history, request access »

ViraTherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a next-generation oncolytic viral therapy platform created for the treatment of cancer. The company develop
Drug Discovery
Rum, Austria
33 As of 2026

Woburn, MA
 

Seal Beach, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViraTherapeutics Competitors (100)

One of ViraTherapeutics’s 100 competitors is Replimune, a Formerly VC-backed company based in Woburn, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Replimune Formerly VC-backed Woburn, MA
Dendreon Formerly VC-backed Seal Beach, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Carisma Therapeutics Formerly VC-backed Philadelphia, PA
Instil Bio Formerly VC-backed Dallas, TX
You’re viewing 5 of 100 competitors. Get the full list »

ViraTherapeutics Patents

ViraTherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230183650-A1 Vsv rescue Active 09-Jul-2021
US-20220088162-A1 Heterologous prime boost vaccine Inactive 14-Sep-2020
US-20250312428-A1 Heterologous prime boost vaccine Pending 14-Sep-2020
US-20220010286-A1 Process for producing a purified rhabdovirus from cell culture Inactive 10-Jul-2020
US-12171795-B2 Recombinant rhabdovirus encoding for a cd80 extracellular domain fc-fusion protein Active 03-Jun-2020 A61K35/766
To view ViraTherapeutics’s complete patent history, request access »

ViraTherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViraTherapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
AplusB Accelerator/Incubator
Austria Wirtschaftsservice Venture Capital Minority
Boehringer Ingelheim Venture Fund Corporate Venture Capital Minority
EMBL Ventures Venture Capital Minority
EMPL Fahrzeugwerk Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

ViraTherapeutics FAQs

  • When was ViraTherapeutics founded?

    ViraTherapeutics was founded in 2013.

  • Where is ViraTherapeutics headquartered?

    ViraTherapeutics is headquartered in Rum, Austria.

  • What is the size of ViraTherapeutics?

    ViraTherapeutics has 33 total employees.

  • What industry is ViraTherapeutics in?

    ViraTherapeutics’s primary industry is Drug Discovery.

  • Is ViraTherapeutics a private or public company?

    ViraTherapeutics is a Private company.

  • What is the current valuation of ViraTherapeutics?

    The current valuation of ViraTherapeutics is .

  • What is ViraTherapeutics’s current revenue?

    The current revenue for ViraTherapeutics is .

  • How much funding has ViraTherapeutics raised over time?

    ViraTherapeutics has raised $8.55M.

  • Who are ViraTherapeutics’s investors?

    AplusB, Austria Wirtschaftsservice, Boehringer Ingelheim Venture Fund, EMBL Ventures, and EMPL Fahrzeugwerk are 5 of 9 investors who have invested in ViraTherapeutics.

  • Who are ViraTherapeutics’s competitors?

    Replimune, Dendreon, Inovio Pharmaceuticals, Carisma Therapeutics, and Instil Bio are some of the 100 competitors of ViraTherapeutics.

  • When was ViraTherapeutics acquired?

    ViraTherapeutics was acquired on 13-Sep-2018.

  • Who acquired ViraTherapeutics?

    ViraTherapeutics was acquired by Boehringer Ingelheim.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process